Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
14 Dec 2023
IME Rheumatology Webinar | Key Insights from ACR 2023 – An Interdisciplinary Expert Roundtable Discussion
This interdisciplinary expert roundtable discussion which highlights data from the American College of Rheumatology (ACR) 2023…
6
Mins
14 Dec 2023
Methotrexate for Rheumatoid Arthritis
Methotrexate is a common first-line treatment for rheumatoid arthritis, yet its widespread and habitual usage often leads physicians…
8 Dec 2023
BIMZELX®▼ (bimekizumab) Mode of Action
Learn about the mechanism of action for Bimzelx (bimekizumab). To find out more, please visit www.bimzelx.eu…
16 Nov 2023
Digital Revolution in Rheumatology
Antoni Chan joins Jonathan to discuss the transformative impact of digital healthcare technologies in rheumatology.
9 Nov 2023
Live Webinar: Key Insights from ACR 2023 - An Interdisciplinary Expert Roundtable Discussion | November 24th 2:30 PM - 3:30 PM GMT
Tune in to this interdisciplinary expert roundtable discussion, which will highlight data from the American College of Rheumatology (ACR) 2023, spotlighting biosimilars.
1 Nov 2023
Methotrexate a Low-Cost, Effective Treatment for Inflammatory Joint Conditions
Researchers from Monash University, Clayton, Victoria, Australia, found that 20 mg weekly methotrexate delivered orally over 6 months reduced pain and stiffness in patients with symptomatic hand osteoarthritis.
31 Oct 2023
Greater Osteoarthritis Progression Observed in Patients Undergoing Meniscal Surgery
Greater osteophyte progression has been observed in patients who underwent arthroscopic meniscal surgery, compared with those receiving physical therapy. Read more.
7
Mins
19 Oct 2023
Atypical Hepatitis B-Associated Vasculitis
One of the many extra-hepatic manifestations of hepatitis B virus (HBV) infections is vasculitis. While the classic HBV-associated…
Loading posts...
« Previous
1
…
35
36
37
38
39
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View